Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#What Does the Forecast Indicate for the Digital Therapeutics Sarcopenia Market From 2025 to 2029?#_x000D_
In recent times, the size of the sarcopenia digital therapeutics market has seen fast-paced growth. Its projected growth from $1.32 billion in 2024 to $1.54 billion in 2025 equals a compound annual growth rate (CAGR) of 16.3%. The surge during this historical period can be credited to factors such as the increase in the aging population, an upswing in the incidence of muscle loss associated with aging, widening awareness of sarcopenia, more widespread adoption of telehealth, a rising demand for rehabilitation based at home, and governmental initiatives endorsing digital healthcare._x000D_
_x000D_
Anticipated to witness a substantial increase in the coming years, the digital therapeutics sarcopenia market is projected to spike to $2.78 billion in 2029 with an annual compound growth rate (CAGR) of 16.0%. This anticipated growth in the forecasted period is credited to factors such as an increasing population of the elderly, heightened emphasis on preventative muscle health, the surge in AI incorporation in digital therapeutics, the expansion of DTx reimbursement policies, the creation of tailor-made exercise plans, the emergence of collaborations amidst technology companies and healthcare providers, and an escalating demand for remote rehabilitation solutions. The forthcoming period is set to see key trends such as enhancements in AI-guided personalized training programs, amalgamation with wearable health tracking devices, the growth of tele-rehabilitation platforms, integration in elderly care, improved remote patient surveillance mechanisms, and progress in digital health solutions._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp_x000D_
_x000D_
#What Elements Are Contributing To Growth In The Digital Therapeutics Sarcopenia Market?#_x000D_
The digital therapeutics sarcopenia market’s expansion is anticipated to be fuelled by an uptick in the occurrence of concurrent health conditions or comorbidities. The term comorbidities signifies the presence of two or more health complications concurrently in an individual. As the population ages, the incidence of comorbidities increases due to a decrease in physiological functions and prolonged exposure to health hazards. Digital therapeutics for sarcopenia can prevent comorbidities, particularly obesity, by promoting regular exercise and muscle strengthening, which can enhance metabolism and decrease fat accumulation. For example, the World Obesity Federation, a UK-based membership organization, predicted in March 2024 that nearly 79% of adults suffering from overweight and obesity-related issues will be residing in low- and middle-income countries by 2035. The total number of adults with obesity is forecasted to increase to 1.53 billion. Thus, the escalating incidence of comorbidities is propelling the growth of the digital therapeutics sarcopenia market._x000D_
_x000D_
#Which Segments Are Detailed In The Global Digital Therapeutics Sarcopenia Market Report?#_x000D_
The digital therapeutics sarcopenia market covered in this report is segmented_x000D_
_x000D_
1) By Product: Software, Devices, Services_x000D_
2) By Distribution Channel: Online Platforms, Pharmacies, Other Distribution Channels _x000D_
3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications_x000D_
4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software_x000D_
2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools_x000D_
3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services_x000D_
_x000D_
#Which Emerging Trends And Strategic Shifts Are Shaping The Digital Therapeutics Sarcopenia Market?#_x000D_
Renowned firms that are central to the sarcopenia digital therapeutics market are striving to develop sophisticated solutions, including drug discovery platforms. These solutions aim to streamline the therapy development process, reinforce treatment outcomes, and expedite the provision of personalized care for muscle wastage due to aging. More specifically, a drug discovery platform enhances the effort and speed to locate and manufacture new drugs effectively through innovative technologies and techniques. For instance, ProFuse Technology, a biotech firm from Israel, launched a novel drug discovery platform in April 2025. This platform is centred around preventing muscle reduction due to age (sarcopenia), GLP-1 weight-loss drugs, and cancer cachexia. The company, using lab-grown muscle tissues that mirror natural muscle, can rapidly and proficiently conduct tests and screen potential drug candidates. This state-of-the-art platform lessens dependency on animal experimentation and minimizes research expenses. ProFuse is broadening its reach from lab-grown meat to biopharmaceuticals, responding to the escalating demand for therapies that preserve muscle, thus introducing a groundbreaking strategy to tackle burgeoning muscle health issues._x000D_
_x000D_
#Who Are The Key Contributors To Growth In The Digital Therapeutics Sarcopenia Market?#_x000D_
Major companies operating in the digital therapeutics sarcopenia market are Noom Inc., Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Virta Health Corp., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Propeller Health, Lark Technologies Inc., mySugr GmbH, SilverCloud Health Limited (a part of Amwell), Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, and Cometa Srl. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
_x000D_
#Which Region Is Projected To Lead The Digital Therapeutics Sarcopenia Market By 2025?#_x000D_
North America was the largest region in the digital therapeutics sarcopenia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27278&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
